315 related articles for article (PubMed ID: 3001420)
21. GnRH analogues for contraception.
Fraser HM
Br Med Bull; 1993 Jan; 49(1):62-72. PubMed ID: 8324616
[TBL] [Abstract][Full Text] [Related]
22. The rapid effects of luteinizing hormone releasing hormone agonists and antagonists on the mouse pituitary in vitro.
Kato K; Sairam MR
Life Sci; 1983 Jan; 32(3):263-70. PubMed ID: 6401836
[TBL] [Abstract][Full Text] [Related]
23. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
24. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
Lemay A; Faure N; Labrie F; Fazekas AT
Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
[TBL] [Abstract][Full Text] [Related]
25. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
[TBL] [Abstract][Full Text] [Related]
26. Compensatory response of the luteinizing-hormone (LH)-releasing hormone (LHRH)/LH pulse generator after administration of a potent LHRH antagonist in the ram.
Lincoln GA; Fraser HM
Endocrinology; 1987 Jun; 120(6):2245-50. PubMed ID: 3032581
[TBL] [Abstract][Full Text] [Related]
27. Influence of testosterone substitution on sperm suppression by LHRH agonists.
Bouchard P; Garcia E
Horm Res; 1987; 28(2-4):175-80. PubMed ID: 2969861
[TBL] [Abstract][Full Text] [Related]
28. Effects of an LHRH agonist analog upon sexual function in male dogs. Suppression, reversibility, and effect of testosterone replacement.
Vickery BH; McRae GI; Briones W; Worden A; Seidenberg R; Schanbacher BD; Falvo R
J Androl; 1984; 5(1):28-42. PubMed ID: 6231277
[TBL] [Abstract][Full Text] [Related]
29. Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men.
Bagatell CJ; Conn PM; Bremner WJ
Fertil Steril; 1993 Oct; 60(4):680-5. PubMed ID: 8405525
[TBL] [Abstract][Full Text] [Related]
30. Recent developments in female contraception: LHRH.
Vijayan E
J Steroid Biochem; 1985 Nov; 23(5B):827-31. PubMed ID: 3935868
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic uses of gonadotropin-releasing hormone analogs.
Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the pituitary-gonadal axis in nude male mice by continuous administration of LHRH agonists and antagonists.
Redding TW; Schally AV
J Endocrinol; 1990 Aug; 126(2):309-15. PubMed ID: 2144873
[TBL] [Abstract][Full Text] [Related]
33. Reproductive pharmacology of LHRH and agonists in females and males.
Corbin A; Bex FJ
Acta Eur Fertil; 1980 Jun; 11(2):113-30. PubMed ID: 7010866
[TBL] [Abstract][Full Text] [Related]
34. On the inhibitory effects of luteinizing hormone-releasing hormone analogs.
Bowers CY; Humphries J; Wasiak T; Folkers K; Reynolds GA; Reichert LE
Endocrinology; 1980 Mar; 106(3):674-83. PubMed ID: 6986259
[TBL] [Abstract][Full Text] [Related]
35. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys.
Burgos-Briceño LA; Schally AV; Bartke A; Asch RH
J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248
[TBL] [Abstract][Full Text] [Related]
37. Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycle.
Monroe SE; Henzl MR; Martin MC; Schriock E; Lewis V; Nerenberg C; Jaffe RB
Fertil Steril; 1985 Mar; 43(3):361-8. PubMed ID: 3156770
[TBL] [Abstract][Full Text] [Related]
38. Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs.
Yen SS
Fertil Steril; 1983 Mar; 39(3):257-66. PubMed ID: 6130985
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRH.
Gudmundsson JA; Nillius SJ; Bergquist C
Contraception; 1984 Aug; 30(2):107-14. PubMed ID: 6238805
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone.
Pavlou SN; Interlandi JW; Wakefield G; Rivier J; Vale W; Rabin D
J Androl; 1986; 7(4):228-33. PubMed ID: 3528106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]